Precision Biosciences (DTIL) Depreciation & Amortization (CF) (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $299000.0 in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $299000.0, down 24.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 43.63% YoY), and the FY2025 annual result was $1.5 million, down 56.82% from the prior year.
• Depreciation & Amortization (CF) retreated to $299000.0 in Q1 2026 per DTIL's latest filing, from $345000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $2.0 million in Q1 2022 and troughed at $299000.0 in Q1 2026.
• A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) grew 1.87% in 2023, then slumped 65.44% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.0 million in 2022, then slumped by 34.74% to $1.3 million in 2023, then sank by 64.82% to $450000.0 in 2024, then declined by 23.33% to $345000.0 in 2025, then dropped by 13.33% to $299000.0 in 2026.
• Business Quant data shows DTIL's Depreciation & Amortization (CF) at $299000.0 in Q1 2026, $345000.0 in Q4 2025, and $309000.0 in Q3 2025.